Formulation and Evaluation of Herbal Gel Containing Kigelia africana(lam.) Benth., Fruits Extract
DOI:
https://doi.org/10.53555/nnas.v2i4.680Keywords:
Kigelia africana(Lam.) Benth., aqueous extract, Carbapol 940, herbal Gel, skin irritationAbstract
Herbal medicine has become an item of global importance, both medicinal and economical. Although usage of these herbal medicines has increased, their quality, safety, and efficiency are serious concerns in industrialized and developing countries. The present research has been undertaken with the aim to formulate and evaluate the herbal gel containing Kigelia africana (Lam.) Benth. fruit extract. The gel formulation was designed by using Carbapol 940, Kigelia africana (Lam.) Benth. fruit extract, propylene glycol, methyl paraben, propyl paraben, and the required amount of distilled water. The skin pH (6.8-7.1) was maintained by dropwise addition of triethanolamine. The physicochemical parameters of formulations (pH, spreadability, stability, etc.) were determined. Stability studies have been carried out as per ICH guidelines for 3 months at different temperatures and humidity. The results showed that a formulation containing Kigelia africana (Lam.) Benth. fruit extract shows better stability. Further formulations have been studied for skin irritation on an animal model (rat), and the results showed that there was no skin irritation to animals.
References
1. Dubey NK, Kumar R, Tripati P. Global promotion of herbal medicines: India’s opportunity. Curr Med 2004; 86: 37-41.
2. Grace OM, Light ME, Lindsey KI, Mulholland DA, van Staden J, Jager AK. Antibacterial activity and isolation of active compounds from fruit of the traditional African medicinal tree Kigelia africana. South Afr J Bot. 2002;68(1):220-222.
3. Cragg GM and Newman DJ, Medicinal for the Millennia, Ann NY Acad Sci 2001, 953, 3-25.
4. Tzu L, Cheng W, Chia C, Shu H, Wang S. Luteolin Inhibits the Release of Glutamate in Rat Cerebrocortical Nerve Terminals. J Agric Food Chem 2011; 59 (15), 8458-66.
5. Guterres SS, Alves MP, Pohlamnn AR. Polymeric nanoparticles, nanospheres, and nanocapsules for cutaneous applications. Drug Target Insights. 2007; 2147-157.
6. Allen L, V Jr. The Basics of Compounding. Int J Pharm Compd. 1999; 3: 385-389.
7. Weller PJ. Handbook of Pharmaceutical Excipients. American Pharmaceutical Association, Washington, DC, 2003, pp. 521-523.
8. Panchangula R, Salve PS, Thomas NS, Jain AK, Ramarao P. Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol, and their binary combinations on permeation through rat skin. Int J Pharm. 2001; 219: 95-105.
9. Sudipta D, Pallab KH, Goutam P. International Journal of PharmTech Research. 2011; 3:140-143.
10. Carl AB, Edward RA. Textbook of clinical chemistry and molecular diagnostics. 4th rev. ed. W.B. Saunders. Philadelphia, 2001.
11. Patel RP, Kamani R. Formulation optimization and evaluation of mometasone furoate cream. J Pharm Res. 2002; 2: 1565-1569.
12. Panigrahi L, Ghosal SK, Pattnaik S, Maharana L, Barik BB. Effect of permeation enhancers on the release and permeation kinetics of lincomycin hydrochloride gel formulations through mouse skin. Indian J Pharm Sci 2006; 205-211
13. Pandit JK, Bharathi D, Srinatha A, Ridhurkar DN, Singh S. Long-acting ophthalmic formulation of indomethacin: Evaluation of alginate gel systems. Ind J Pharm Sci. 2007; 69: 37-40.
14. Das K, Dang R, Machale UM. The Pharma Review. 2010; 8:112.
15. Prakash RP, Rao R. J. pharmaceutical and clinical research. 2010; 3: 126-129.
Downloads
Published
Issue
Section
License
Copyright (c) 2015 R. Bhramaramba, M. Harsha Vardahan Chowdary, K. Bharath Lova, A. Nagarjuna (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.